Pharsight

Drugs that contain Oxcarbazepine

1. Oxtellar Xr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7722898 SUPERNUS PHARMS Modified-release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(3 years from now)

US9855278 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(3 years from now)

US9351975 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(3 years from now)

US10220042 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(3 years from now)

US9119791 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(3 years from now)

US7910131 SUPERNUS PHARMS Method of treating seizures using modified release formulations of oxcarbazepine
Apr, 2027

(3 years from now)

US11166960 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(3 years from now)

US8821930 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(3 years from now)

US8617600 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(3 years from now)

US9370525 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(3 years from now)

Market Authorisation Date: 19 October, 2012

Treatment: Treatment of partial-onset seizures

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of OXTELLAR XR before it's drug patent expiration?
More Information on Dosage

OXTELLAR XR family patents

Family Patents